1 / 1

Polycythemia Vera Market

The total prevalent population of Polycythemia Vera in the 7MM was 283,442 in 2017. The estimates show the highest prevalence of Polycythemia Vera in the United States with 157,290 cases in 2017. It is also observed that Males are more affected by Polycythemia Vera as compared to females in the 7MM market.<br><br>The therapeutic market of Polycythemia Vera in the seven major markets was assessed to be USD 951.68 Million in 2017 and is expected to grow during the study period (2017u20132030).<br><br>The key players in the Polycythemia Vera Market includes Kartos Therapeutics, Italfarmaco, Protagonist Therapeutics, Roche/Promedior, Geron Corporation, Imago BioSciences and others.<br><br>For more detailed information on Polycythemia Vera market, visit: <br>https://www.delveinsight.com/report-store/polycythemia-vera-market<br>

DelveInsight
Download Presentation

Polycythemia Vera Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related